Palvella Therapeutics, Inc. (PVLA) ownership: Top institutional holder: SUVRETTA CAPITAL MANAGEMENT, LLC ($143.78M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1153496.00 | $143.78M | 2026-03-31 |
| First Light Asset Management, LLC | 980758.00 | $122.25M | 2026-03-31 |
| BVF INC/IL | 960989.00 | $119.79M | 2026-03-31 |
| Frazier Life Sciences Management, L.P. | 882400.00 | $109.99M | 2026-03-31 |
| BlackRock, Inc. | 686853.00 | $85.62M | 2026-03-31 |
| JENNISON ASSOCIATES LLC | 640611.00 | $79.85M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 477294.00 | $59.49M | 2026-03-31 |
| VANGUARD GROUP INC | 560616.00 | $58.68M | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-12 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 |
Back to PVLA overview · PVLA earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.